Epigenetics of cancer stem cells: Pathways and therapeutics is a research paper published in Biochimica et Biophysica Acta (BBA) - General Subjects (2014). On theSindex it has a DataRank of 0.735. It has been cited 133 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.735
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →CSIR-EpiHeD-Network Scheme
Grant: BSC0118
Science & Engineering Research Board
Grant: SR/FT/LS-80/2011
Department of Biotechnology-Twinning Programme
Grant: BCIL/NER-BPMC/2013/722
Keywords
Additional file 1 of Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment
Additional file 1 of Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment
Additional file 1 of CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes
Additional file 1 of CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes